Biologics Spine Fziomed Initiates Commercialization of Oxiplex Gel in the United States byJosh SandbergNovember 5, 2025
Regulatory Spine Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery byTim AllenJuly 8, 2025
Spine FzioMed Enrolls Patient Number Fifty in Clinical Study to Support the Effectiveness and Safety of Oxiplex® for the Reduction of Pain and Symptoms Following Lumbar Surgery byJosh SandbergMarch 29, 2019
Hospitals FzioMed Receives FDA Approval for Small Confirmatory Study of Oxiplex® in Patients Undergoing Lumbar Surgery for Disc Herniation byJosh SandbergOctober 24, 2017
